Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: Providence RI, Worcester MA, New Haven CT, New York NY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase 3, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Montreal, Fairfax VA, Durham NC, Toronto,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase 1, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
for
Severe Asthma
Location: Fall River MA, New York NY, Williamsburg VA, Miami FL,
Sponsor: Generate Biomedicines
Sex: All
Age: 12 - 70+
Code: NCT07359846
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Impact of Cannabis Use During Third Molar Surgery
for
Cannabis Use, Marijuana Usage, Sedation and Analgesia,
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 16 - 70+
Code: NCT07423195
Recruiting
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
for
Neoplasms, Colorectal, Neoplasms
Location: Toronto, Montreal, Hamilton, Canton OH, Detroit MI,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07213609
Phase 1, Phase 2, Recruiting
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
for
Gout
Location: Suffolk VA, Duncansville PA, Hialeah FL, Miami FL,
Sponsor: Protalix
Sex: All
Age: 18+
Code: NCT07280156
Phase 2, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Stony Brook NY, Lake Success NY, Manhasset NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase 2, Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: St. John's, Boston MA, Farmington CT, Baltimore MD,
Sponsor: Incyte Corporation
Sex: All
Age: 12 - 17
Code: NCT07213973
Phase 2, Recruiting
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
for
Sickle Cell Disease Vaso-occlusive Crisis
Location: The Bronx NY, New York NY, Baltimore MD, Greenville NC,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT06699849
Phase 2, Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Stamford CT, Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06998940
Phase 3, Recruiting
The ArtixASCEND Study
for
Acute Lower Limb Arterial Occlusion
Location: Boston MA, New Haven CT, Stony Brook NY, Brooklyn NY,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT07135895
Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Westerly RI, Waterford CT, Guilford CT, North Haven CT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase 2, Phase 3, Recruiting
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: New Haven CT, Lake Success NY, Grand Rapids MI
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07387068
Phase 1, Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
for
Congenital Diaphragmatic Hernia
Location: Boston MA, Charleston SC, Atlanta GA, Ann Arbor MI,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT05213676
Recruiting
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for
Hepatitis
Location: Boston MA, Worcester MA, Manhasset NY, The Bronx NY,
Sponsor: Bausch Health Americas, Inc.
Sex: All
Age: 18+
Code: NCT07428538
Phase 3, Recruiting
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
for
Multiple Myeloma, Secondary Immunodeficiency
Location: Albany NY, Montreal, Baltimore MD, Detroit MI,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06980480
Phase 3, Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
for
Overweight, Obesity
Location: Boston MA, Waltham MA, New Haven CT, Waterbury CT,